md 770222 has been researched along with cimoxatone in 6 studies
| Studies (md 770222) | Trials (md 770222) | Recent Studies (post-2010) (md 770222) | Studies (cimoxatone) | Trials (cimoxatone) | Recent Studies (post-2010) (cimoxatone) |
|---|---|---|---|---|---|
| 6 | 2 | 0 | 26 | 3 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garrick, NA; Linnoila, M; Murphy, DL; Seppala, T | 1 |
| Chanoine, F; Rovei, V; Strolin Benedetti, M; Tillement, JP; Zini, R | 1 |
| Deniker, P; Lesage, A; Lôo, H; Olié, JP; Poirier, MF; Rovei, V; Strolin Benedetti, M | 1 |
| Dordain, G; Dostert, P; Eschalier, A; Lesage, A; Rovei, V; Strolin Benedetti, M; Zarifian, E | 1 |
| Boucher, T; Fowler, CJ; Strolin Benedetti, M | 1 |
| Rigal, M; Rovei, V; Sanjuan, M; Thiola, A | 1 |
2 trial(s) available for md 770222 and cimoxatone
| Article | Year |
|---|---|
[Antidepressive action, pharmacokinetic characteristics and biochemical properties of cimoxatone, a new reversible MAO-A inhibitor].
Topics: Adult; Clinical Trials as Topic; Depressive Disorder; Female; Humans; Kinetics; Male; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Prolactin | 1983 |
Effect of a reversible and selective MAO-A inhibitor (cimoxatone) on diurnal variation in plasma prolactin level in man.
Topics: Adult; Circadian Rhythm; Humans; Hydrocortisone; Kinetics; Male; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Prolactin | 1984 |
4 other study(ies) available for md 770222 and cimoxatone
| Article | Year |
|---|---|
Rhesus monkey cerebrospinal fluid amine metabolite changes following treatment with the reversible monoamine oxidase type-A inhibitor cimoxatone.
Topics: Animals; Biogenic Amines; Dose-Response Relationship, Drug; Homovanillic Acid; Hydroxyindoleacetic Acid; Macaca mulatta; Male; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones | 1985 |
Plasma protein binding of the reversible type A MAO inhibitor cimoxatone (MD 780515).
Topics: Bilirubin; Blood Proteins; gamma-Globulins; Humans; Lipoproteins; Monoamine Oxidase Inhibitors; Orosomucoid; Oxazoles; Oxazolidinones; Serum Albumin; Tryptophan | 1983 |
The deamination of noradrenaline and 5-hydroxytryptamine by rat brain and heart monoamine oxidase and their inhibition by cimoxatone, toloxatone and MD 770222.
Topics: Animals; Brain; Deamination; In Vitro Techniques; Kinetics; Male; Mitochondria; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Myocardium; Nerve Tissue Proteins; Norepinephrine; Oxazoles; Oxazolidinones; Rats; Rats, Inbred Strains; Serotonin | 1983 |
High-performance liquid chromatographic determination of cimoxatone and its O-demethyl metabolite in plasma.
Topics: Adult; Chromatography, High Pressure Liquid; Humans; Kinetics; Oxazoles; Oxazolidinones | 1983 |